Royal Bank of Canada’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39K | Buy |
24,612
+24,102
| +4,726% | +$38.2K | ﹤0.01% | 5643 |
|
|
2025
Q1 | $0 | Sell |
510
-933
| -65% | – | ﹤0.01% | 6605 |
|
|
2024
Q4 | $2K | Sell |
1,443
-1,204
| -45% | -$1.67K | ﹤0.01% | 6226 |
|
|
2024
Q3 | $14K | Buy |
2,647
+1,767
| +201% | +$9.35K | ﹤0.01% | 5766 |
|
|
2024
Q2 | $6K | Sell |
880
-9,744
| -92% | -$66.4K | ﹤0.01% | 6102 |
|
|
2024
Q1 | $127K | Buy |
10,624
+8,010
| +306% | +$95.8K | ﹤0.01% | 4615 |
|
|
2023
Q4 | $20K | Buy |
2,614
+1,503
| +135% | +$11.5K | ﹤0.01% | 5774 |
|
|
2023
Q3 | $5K | Buy |
1,111
+514
| +86% | +$2.31K | ﹤0.01% | 6116 |
|
|
2023
Q2 | $21K | Buy |
597
+100
| +20% | +$3.52K | ﹤0.01% | 5734 |
|
|
2023
Q1 | $10K | Sell |
497
-399
| -45% | -$8.03K | ﹤0.01% | 5930 |
|
|
2022
Q4 | $19K | Buy |
896
+824
| +1,144% | +$17.5K | ﹤0.01% | 5853 |
|
|
2022
Q3 | $2K | Buy |
72
+38
| +112% | +$1.06K | ﹤0.01% | 6556 |
|
|
2022
Q2 | $1K | Sell |
34
-316
| -90% | -$9.29K | ﹤0.01% | 6704 |
|
|
2022
Q1 | $12K | Sell |
350
-677
| -66% | -$23.2K | ﹤0.01% | 6393 |
|
|
2021
Q4 | $28K | Buy |
1,027
+486
| +90% | +$13.3K | ﹤0.01% | 6114 |
|
|
2021
Q3 | $23K | Sell |
541
-1,826
| -77% | -$77.6K | ﹤0.01% | 6110 |
|
|
2021
Q2 | $118K | Buy |
2,367
+2,067
| +689% | +$103K | ﹤0.01% | 5021 |
|
|
2021
Q1 | $14K | Buy |
+300
| New | +$14K | ﹤0.01% | 6140 |
|
|
2020
Q3 | – | Sell |
-17
| Closed | – | – | 6281 |
|
|
2020
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 6259 |
|
|
2020
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 6276 |
|
|
2019
Q4 | $0 | Buy |
+17
| New | – | ﹤0.01% | 6310 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5893 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5952 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6055 |
|